NCT01452308View on ClinicalTrials.gov

Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

August 31, 2013

Conditions

Liver Fibrosis

Interventions

BIOLOGICAL

Simtuzumab

Trial Locations (1)

10065

Weill Cornell Medical College: NewYork-Presbyterian Hospital, New York

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY